The committee is supposed to submit its report in 90 days. It has been tasked to examine the provisions of stakeholder departments with respect to pharmaceutical marketing practices and align the interventions for effective implementation among health care providers and industry. The committee will also examine the related issues on the requirement of “legally enforceable mechanism” for regulating marketing practices, including study of the practices across the globe”.
Subscribe To Our Free Newsletter |